Invention Grant
- Patent Title: Pyrrolotriazines as potassium ion channel inhibitors
- Patent Title (中): 吡咯并三嗪作为钾离子通道抑制剂
-
Application No.: US14200055Application Date: 2014-03-07
-
Publication No.: US09050345B2Publication Date: 2015-06-09
- Inventor: Heather Finlay , Ashok Kumar Adisechan , Naveen Kumar Dhondi , Kavitha Govindrajulu , Prashantha Gunaga , John Lloyd , Pothukanuri Srinivasu
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Mary K. VanAtten
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D401/04 ; C07D401/14 ; C07D403/04 ; C07D403/14 ; A61K31/53 ; A61P9/06 ; A61P9/04 ; C07D405/04 ; C07D405/14 ; C07D413/04 ; C07D413/14 ; C07D417/04 ; A61K31/5377 ; C07D519/00

Abstract:
A compound of formula (I) wherein A, R1, R3, and R24 are described herein. The compounds are useful as inhibitors of potassium channel function and in the treatment of arrhythmia, maintaining normal sinus rhythm, IKur-associated disorders, and other disorders mediated by ion channel function.
Public/Granted literature
- US20140256719A1 PYRROLOTRIAZINES AS POTASSIUM ION CHANNEL INHIBITORS Public/Granted day:2014-09-11
Information query